Navidea Biopharmaceuticals Inc (OTCPK:NAVB)
$ 0.0001 0 (0%) Market Cap: 10,000.00 Enterprise Value: -2.60 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

Q1 2022 Navidea Biopharmaceuticals Inc Earnings Call Transcript

May 12, 2022 / 09:00PM GMT
Release Date Price: $0.72 (-7.10%)
Operator

Welcome to the Navidea Biopharma's First Quarter 2021 Earnings Call and Business Update.

I will now turn the call over to the Chief Medical Officer for Navidea, Michael Rosol. You may begin.

Michael Stanley Rosol
Navidea Biopharmaceuticals, Inc. - Senior VP & Chief Medical Officer

Thank you, and thank you all for joining us for today's earnings call. This call is being webcast live on our website, ir.navidea.com, and a replay will be made available. Following prepared remarks, we will be conducting a live Q&A session. Navidea's Vice President of Finance and Administration, Erika Eves will be joining me on the call today. .

During the course of this conference call, we will be making forward-looking statements regarding future events and the future performance of the company. These events relate to our business plans to develop Navidea's molecular diagnostics and immunotherapeutics, which include clinical and regulatory developments and timing of clinical data readouts, along with capital resources and strategic matters as well as the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot